purpos
influenza
patient
selflimit
respiratori
ill
hospit
patient
develop
sever
diseas
requir
icu
admiss
aim
studi
identifi
influenzaspecif
factor
associ
icu
admiss
mortal
furthermor
influenzaspecif
pulmonari
bacteri
fungal
viral
coinfect
investig
method
influenza
patient
admit
two
academ
hospit
netherland
investig
admit
icu
result
histori
obstructivecentr
sleep
apnea
syndrom
myocardi
infarct
dyspnea
influenza
type
bmi
n
develop
renal
failur
bacteri
fungal
coinfect
observ
frequent
patient
admit
icu
compar
patient
normal
ward
coinfect
evid
icuadmit
patient
compar
patient
normal
ward
mainli
caus
staphylococcu
aureu
streptococcu
pneumonia
aspergillu
fumigatu
nonsurvivor
suffer
diabet
mellitu
preexist
renal
failur
often
conclus
current
studi
indic
histori
osascsa
myocardi
infarct
bmi
n
might
relat
icu
admiss
influenza
patient
second
icu
patient
develop
pulmonari
coinfect
last
preexist
renal
failur
diabet
mellitu
often
observ
nonsurvivor
influenza
viru
infect
import
caus
mortal
worldwid
lead
death
year
develop
world
influenza
patient
selflimit
respiratori
ill
hospit
patient
may
develop
sever
dyspnea
respiratori
distress
requir
icu
admiss
mortal
caus
primari
viral
infect
fulmin
diseas
cours
also
influenzaassoci
pulmonari
coinfect
increasingli
recogn
similar
sepsi
influenza
initi
immunosuppress
mechan
creat
ideal
environ
opportunist
pathogen
grow
induc
coinfect
pulmonari
bacteri
coinfect
predominantli
caus
streptococcu
pneumonia
staphylococcu
aureu
haemophilu
influenza
also
invas
pulmonari
aspergillosi
ipa
caus
fungal
aspergillu
fumigatu
recent
recogn
coinfect
occur
influenza
patient
admit
intens
care
unit
icu
bacteri
well
fungal
pulmonari
coinfect
associ
increas
mortal
rate
addit
viral
coinfect
reactiv
virus
resid
latent
host
cytomegaloviru
cmv
epstein
barr
viru
ebv
herp
simplex
viru
hsv
frequent
encount
influenza
patient
well
whether
infect
associ
increas
mortal
mere
reflect
manifest
immunosuppress
elucid
yet
influenza
patient
repres
heterogen
patient
popul
present
variou
age
categori
comorbid
often
treat
divers
rang
medic
therapi
antibiot
antivir
immunosuppress
drug
due
heterogen
fulli
clarifi
factor
protect
factor
hand
associ
increas
mortal
patient
although
impact
season
influenza
vari
depend
type
viru
time
season
vaccin
coverag
effect
vaccin
rate
influenzaassoci
hospit
place
substanti
burden
health
care
resourc
importantli
earli
recognit
certain
factor
influenc
diseas
cours
influenzainfect
patient
may
improv
current
therapi
strategi
present
studi
investig
cohort
influenza
patient
season
admit
two
univers
hospit
netherland
identifi
factor
relat
icu
admiss
mortal
addit
investig
incid
influenzaassoci
pulmonari
coinfect
caus
pathogen
relationship
icu
admiss
mortal
data
collect
influenza
patient
admit
radboud
univers
medic
center
radboudumc
maastricht
univers
medic
center
mumc
locat
netherland
local
institut
review
board
approv
protocol
metc
cmo
influenza
epidem
start
novemb
end
may
accord
nation
institut
health
environ
rivm
rapport
patient
admit
particip
hospit
octob
april
check
elig
studi
case
identifi
use
databas
microbiolog
depart
medic
center
patient
admit
hospit
clinic
symptom
due
acut
infect
influenza
b
includ
viru
sampl
obtain
nosethroat
swab
sputum
bronchoalveolar
lavag
bal
laboratori
microbiolog
hospit
confirm
novel
influenza
infect
posit
polymeras
chain
reaction
pcr
diagenod
belgium
either
influenza
influenza
b
distinct
made
selfreferr
schedul
admiss
emerg
hospit
admiss
patient
initi
admit
region
hospit
admitt
one
univers
medic
center
includ
met
case
definit
receiv
antibiot
antivir
treatment
admiss
patient
posit
influenza
pcr
alreadi
admit
hospit
exclud
studi
sampl
collect
part
routin
screen
prior
symptom
infect
observ
initi
day
hospit
admiss
defin
day
detail
inform
collect
demograph
comorbid
medic
condit
use
immunosuppress
medic
hospit
chemotherapi
selfreport
date
onset
ill
clinic
sign
symptom
present
need
treatment
icu
occurr
organ
failur
develop
bacteri
fungal
viral
coinfect
use
neuraminidas
inhibitor
oseltamivir
need
antimicrobi
therapi
final
outcom
bmi
subdivid
underweight
kgm
normal
weight
kgm
overweight
kgm
obes
kgm
pregnanc
defin
gestat
age
confirm
ultrasonographi
exsmok
stop
smoke
within
last
month
consid
activ
smoker
occasion
alcohol
consumpt
defin
intern
unit
iu
week
regular
alcohol
consumpt
defin
iuweek
use
medic
chemotherapi
defin
current
use
use
former
month
comorbid
medic
condit
includ
osa
defin
apneahypopnea
index
ahi
associ
symptom
eg
excess
daytim
sleepi
fatigu
impair
cognit
ahi
greater
regardless
associ
symptom
csa
defin
ahi
n
respiratori
event
occur
without
respiratori
effort
associ
symptom
either
excess
sleepi
disrupt
sleep
asthma
chronic
obstruct
pulmonari
diseas
copd
pulmonari
diseas
hypertens
myocardi
infarct
heart
failur
cardiovascular
diseas
hepat
diseas
renal
diseas
stroke
neurolog
neurodegen
diseas
diabet
mellitu
endocrin
diseas
autoimmun
diseas
malign
comorbid
consid
present
mention
patient
medic
file
use
typic
medic
particular
condit
eg
insulin
therapi
diabet
mellitu
comorbid
consid
absent
medic
file
state
patient
previous
healthi
patient
delay
defin
number
day
onset
ill
hospit
admiss
length
stay
either
hospit
icu
defin
number
day
admiss
discharg
death
readmiss
day
discharg
consid
continu
stay
icu
admiss
criteria
includ
quick
deterior
diseas
cours
potenti
need
vasopress
therapi
andor
mechan
ventil
organ
failur
defin
point
sofa
scale
score
particular
organ
system
circulatori
failur
defin
mean
arteri
pressur
map
mmhg
decreas
map
mmhg
rel
baselin
need
vasopress
therapi
intraven
fluid
mlkg
h
respiratori
failur
defin
need
form
respiratori
support
hepat
failur
total
bilirubin
level
n
central
nerv
system
cn
failur
glasgow
coma
scale
gc
absenc
sed
opioid
delirium
hematolog
failur
defin
leukopenia
thrombocytopenia
andor
anemia
renal
failur
defin
twofold
rise
serum
creatinin
level
rel
baselin
reduct
glomerular
filtrat
rate
gfr
urin
product
mlkgh
h
diseas
sever
score
sap
apach
iii
calcul
icu
patient
pulmonari
bacteri
coinfect
defin
posit
bacteri
cultur
either
endotrach
endobronchi
secret
posit
urin
pneumococc
antigen
test
combin
start
antimicrobi
therapi
pulmonari
fungal
infect
detect
fungal
cultur
endotrach
endobronchi
secret
galactomannan
optic
index
bal
serum
within
three
week
influenza
diagnosi
viral
infect
pneumocysti
jirovecii
infect
detect
pcr
base
recent
work
van
de
veerdonk
et
al
critic
ill
influenza
patient
posit
fungal
cultur
deep
pulmonari
materi
endotrach
endobronchi
secret
consid
posit
pulmonari
fungal
infect
oseltamivir
start
accord
local
hospit
protocol
consequ
radboudumc
start
influenza
patient
suffer
clinic
symptom
day
admiss
mumc
oseltamivir
start
influenza
patient
symptom
h
admiss
except
includ
immunocompromis
patient
patient
interstiti
secondari
bacteri
pneumonia
patient
oseltamivir
start
even
h
data
abstract
patient
record
includ
admiss
histori
daili
doctor
report
discharg
letter
physic
measur
laboratori
inform
system
inform
icu
surveil
system
categor
data
analyz
use
fisher
exact
test
continu
variabl
analyz
use
binari
logist
regress
pvalu
twosid
valu
consid
statist
signific
statist
analys
perform
use
spss
statist
window
version
ibm
corp
armonk
ny
usa
univari
descript
analysi
perform
identifi
risk
factor
icu
admiss
patient
admit
hospit
influenza
viru
infect
chisquar
test
onesid
fisher
exact
test
use
dichotom
variabl
unpair
ttest
normal
distribut
continu
variabl
mannwhitney
u
test
nonnorm
distribut
continu
data
result
verifi
logist
regress
model
next
multivari
logist
regress
use
identifi
independ
risk
factor
variabl
signific
level
p
b
select
greatest
odd
ratio
includ
number
case
icugroup
individu
variabl
multivari
model
test
interact
odd
ratio
confid
interv
ci
calcul
individu
risk
factor
total
case
identifi
data
one
patient
miss
lot
valu
exclud
analysi
demograph
characterist
remain
patient
list
tabl
median
age
entir
patient
popul
yr
includ
children
yr
elderli
patient
yr
patient
histori
pulmonari
diseas
predominantli
copd
preexist
hypertens
report
patient
preexist
neurolog
renal
hepat
diseas
document
patient
admiss
patient
consid
immunocompromis
system
use
steroid
immunosuppress
drug
evid
hospit
median
durat
hospit
day
overal
mortal
rate
major
patient
suffer
influenza
type
tabl
supplementari
materi
influenza
subtyp
perform
patient
type
influenza
show
suffer
subtyp
cough
fever
dyspnea
defin
subject
feel
short
breath
gener
discomfort
common
report
symptom
admiss
oseltamivir
administ
admiss
patient
patient
alreadi
receiv
antibiot
treatment
hospit
admiss
patient
administ
antibiot
treatment
upon
hospit
admiss
patient
receiv
antibiot
later
time
point
hospit
empir
treatment
icu
communityacquir
pneumonia
consist
ceftriaxon
mg
mg
time
day
piperacillintazobactam
mg
time
day
hospitalacquir
pneumonia
accord
dutch
nation
guidelin
communityacquir
pneumonia
adult
swab
antibiot
regim
deescal
bacteri
sputum
cultur
becam
posit
specif
bacteri
pathogen
influenza
patient
admit
icu
median
day
develop
first
symptom
patient
admit
icu
mean
age
year
respiratori
failur
main
caus
icu
admiss
patient
receiv
invas
mechan
ventil
imv
patient
receiv
noninvas
ventil
nonrebreath
mask
appli
one
patient
median
durat
imv
day
nitric
oxid
inhal
use
patient
epoprostenol
inhal
patient
one
patient
receiv
pulmonari
support
therapi
factor
relat
icu
admiss
shown
tabl
osascsa
vs
p
histori
myocardi
infarct
vs
p
bmi
vs
p
often
observ
patient
admit
icu
relat
found
age
icu
admiss
p
influenza
infect
occur
often
icu
popul
compar
influenza
b
vs
p
addit
patient
admit
icu
develop
renal
failur
vs
p
b
secondari
bacteri
vs
p
b
fungal
pulmonari
infect
vs
p
b
often
hospit
stay
compar
influenza
patient
admit
icu
oseltamivir
administ
frequent
patient
vs
p
b
multivari
analysi
age
yr
osascsa
histori
myocardi
infarct
dyspnea
influenza
type
identifi
independ
factor
relat
icu
admiss
influenza
patient
tabl
influenzaassoci
pulmonari
coinfect
caus
pathogen
list
tabl
cours
admiss
hospit
patient
develop
pulmonari
coinfect
either
bacteri
fungal
viral
origin
combin
pathogen
proport
coinfect
icuadmit
patient
significantli
higher
compar
patient
normal
ward
p
b
evid
bacteri
fungal
viral
pathogen
p
p
p
respect
common
bacteri
pathogen
includ
staphylococcu
aureu
streptococcu
pneumonia
aspergillu
fumigatu
common
among
fungal
pathogen
follow
pneumocysti
jirovecii
patient
pulmonari
coinfect
receiv
oseltamivir
often
ci
p
associ
observ
use
immunosuppress
drug
hospit
develop
pulmonari
coinfect
also
relationship
found
develop
pulmonari
coinfect
icu
mortal
ci
p
present
studi
support
high
morbid
mortal
rate
influenza
patient
admit
icu
describ
previou
work
independ
factor
relat
icu
admiss
season
influenza
outbreak
influenza
type
dyspnea
histori
myocardi
infarct
osascsa
coinfect
bacteri
data
patient
miss
data
patient
miss
durat
first
symptom
hospit
admiss
fungal
viral
pathogen
develop
often
patient
admit
icu
similar
previou
season
data
indic
preexist
respiratori
diseas
associ
icu
admiss
influenza
season
databas
dyspnea
appear
determin
clinic
sign
influenzaassoci
icu
admiss
also
osascsa
could
new
independ
factor
relat
icu
admiss
although
total
number
patient
group
possibl
decreas
breath
qualiti
weaken
pulmonari
function
osascsa
patient
therebi
increas
risk
icu
admiss
mechan
may
influenc
pulmonari
function
well
activ
sympathet
nervou
system
vascular
endotheli
dysfunct
inflamm
oxid
stress
describ
osa
csasrel
cardiovascular
complic
number
patient
cohort
influenza
viru
infect
substanti
higher
number
patient
influenza
b
viru
infect
usual
case
influenza
epidem
preval
studi
cohort
repres
global
preval
subtyp
commun
influenza
season
studi
patient
influenza
type
admit
often
icu
patient
subtyp
b
probabl
due
preval
circul
subtyp
season
addit
associ
sever
diseas
cours
higher
mortal
rate
compar
influenza
b
influenza
subtyp
like
less
virul
current
studi
hospit
influenza
patient
admit
icu
describ
literatur
could
due
select
patient
compos
databas
two
tertiari
center
netherland
overal
repres
sever
ill
therefor
logic
associ
increas
number
icu
admiss
icu
popul
treat
often
oseltamivir
comparison
patient
normal
ward
oseltamivir
neuraminidas
inhibitor
block
viral
neuraminidas
enzym
essenti
releas
newli
form
virion
host
cell
cochran
analysi
conclud
oseltamivir
reduc
time
first
allevi
symptom
h
effect
hospit
risk
oseltamivir
effect
mortal
among
patient
type
influenza
pandem
studi
oseltamivir
administ
everi
influenza
patient
upon
admiss
except
clinic
symptom
preval
day
like
reflect
less
sever
influenza
diseas
cours
patient
increas
use
oseltamivir
patient
admit
icu
therefor
like
due
select
bia
true
risk
factor
icu
admiss
also
increas
trend
icu
mortal
observ
system
use
steroid
nonsteroid
immunosuppress
drug
hospit
latter
suggest
immunosuppress
state
caus
preexist
immunomodulatori
therapi
direct
result
influenza
infect
lead
increas
suscept
toward
secondari
infect
might
influenc
diseas
cours
prognosi
influenza
infect
research
need
identifi
risk
factor
complic
diseas
cours
coinfect
often
observ
patient
admit
icu
could
probabl
result
influenzainduc
immunosuppress
state
hamper
initi
adequ
immun
respons
erad
invad
pathogen
expect
staphylococcu
aureu
streptococcu
pneumonia
common
bacteri
pathogen
determin
preval
respect
influenza
patient
icu
caus
transit
normal
colon
upper
respiratori
tract
infecti
diseas
influenza
predispos
secondari
infect
direct
effect
includ
disrupt
epitheli
cell
barrier
suppress
product
antibacteri
peptid
upregul
bacteri
adhes
molecul
also
indirect
immunomodulatori
effect
impair
antigen
present
capac
drain
lymph
node
alter
express
costimulatori
molecul
cell
surfac
receptor
high
incid
fungal
coinfect
subgroup
icu
patient
particular
caus
aspergillu
fumigatu
line
previou
report
show
pathogen
aspergillu
fumigatu
observ
influenza
patient
high
incid
coinfect
caus
streptococcu
pneumonia
staphylococcu
aureu
aspergillu
fumigatu
indic
specif
immun
defect
could
present
influenza
patient
increas
suscept
toward
pathogen
current
investig
data
indic
although
pulmonari
coinfect
often
observ
icu
patient
compar
patient
normal
ward
necessarili
associ
increas
mortal
major
previou
studi
illustr
increas
mortal
result
infect
staphylococcu
aureu
pseudomona
aeruginosa
aspergillu
spp
follow
influenza
infect
possibl
increas
mortal
could
demonstr
due
low
number
patient
current
studi
note
exclud
high
incid
pulmonari
fungal
bacteri
coinfect
current
studi
relat
select
bia
select
hospit
studi
tertiari
hospit
gener
receiv
sever
ill
influenza
patient
popul
inhospit
mortal
icu
mortal
reach
major
patient
die
therapyresist
respiratori
failur
multiorgan
failur
rel
high
mortal
rate
may
attribut
influenza
viru
howev
season
influenza
epidem
netherland
result
increas
mortal
compar
previou
season
outbreak
rivm
rapport
like
high
inhospit
icuassoci
mortal
reflect
referr
function
univers
medic
center
limit
studi
includ
larg
spread
data
rel
small
sampl
size
studi
cohort
aris
one
season
outbreak
subsequ
limit
event
regress
model
also
method
analys
could
influenc
data
current
studi
use
frequentist
interpret
view
probabl
limit
rel
frequenc
event
larg
number
trial
instead
exampl
bayesian
approach
condit
probabl
event
base
data
well
prior
inform
event
condit
relat
event
taken
account
factor
influenc
scientif
impact
data
howev
even
limit
number
studi
subject
independ
risk
factor
sever
statist
signific
relationship
identifi
use
multivari
logist
regress
analysi
howev
complic
logic
occur
sever
ill
one
could
suggest
factor
would
therefor
mere
reflect
diseas
sever
true
risk
factor
nevertheless
despit
limit
valid
due
larg
spread
small
sampl
size
identifi
factor
may
contribut
complic
diseas
cours
could
repres
tool
earli
recognit
influenza
patient
risk
complic
diseas
cours
current
studi
indic
histori
osascsa
myocardi
infarct
dyspnea
influenza
type
bmi
n
develop
renal
failur
bacteri
fungal
coinfect
observ
frequent
influenza
patient
admit
icu
compar
patient
normal
ward
also
pulmonari
coinfect
observ
often
icu
patient
mainli
caus
staphylococcu
aureu
streptococcu
pneumonia
aspergillu
fumigatu
last
nonsurvivor
suffer
diabet
mellitu
preexist
renal
failur
often
studi
approv
local
medic
ethic
committe
metc
cmo
inform
consent
patient
waiv
anonym
natur
data
